Showing 1 - 10 results of 10 for search 'Albrecht Stenzinger', query time: 0.14s Refine Results
  1. 1
    Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types

    Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types by Jan Budczies, Carsten Denkert, Balázs Győrffy, Peter Schirmacher, Albrecht Stenzinger

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    SWI/SNF-deficient undifferentiated/rhabdoid carcinoma of the gallbladder carrying a POLE mutation in a 30-year-old woman: a case report

    SWI/SNF-deficient undifferentiated/rhabdoid carcinoma of the gallbladder carrying a POLE mutation in a 30-year-old woman: a case report by Tiemo S. Gerber, Abbas Agaimy, Arndt Hartmann, Michael Habekost, Wilfried Roth, Albrecht Stenzinger, Peter Schirmacher, Beate K. Straub

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer

    Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer by David Gonzalez, Joaquin Mateo, Albrecht Stenzinger, Federico Rojo, Michelle Shiller, Alexander W Wyatt, Frédérique Penault‐Llorca, Leonard G Gomella, Ros Eeles, Anders Bjartell

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types

    Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types by Jan Budczies, Klaus Kluck, Susanne Beck, Iordanis Ourailidis, Michael Allgäuer, Michael Menzel, Daniel Kazdal, Lukas Perkhofer, Alexander Kleger, Peter Schirmacher, Thomas Seufferlein, Albrecht Stenzinger

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Cellular dissociation grading on biopsies of pulmonary squamous cell carcinoma provides prognostic information across all stages and is congruent with resection specimen grading

    Cellular dissociation grading on biopsies of pulmonary squamous cell carcinoma provides prognostic information across all stages and is congruent with resection specimen grading by Moritz Jesinghaus, Melanie Boxberg, Maxime Schmitt, Mark Kriegsmann, Alexander Harms, Corinna Lang, Thomas Muley, Hauke Winter, Katharina Kriegsmann, Arne Warth, Albrecht Stenzinger, Carsten Denkert, Hans Hoffmann, Seyer Safi, Wilko Weichert

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    First proficiency testing for NGS‐based and combined NGS‐ and FISH‐based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma

    First proficiency testing for NGS‐based and combined NGS‐ and FISH‐based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma by Olaf Neumann, Ulrich Lehmann, Stephan Bartels, Nicole Pfarr, Thomas Albrecht, Katharina Ilm, Jens Christmann, Anna‐Lena Volckmar, Hannah Goldschmid, Martina Kirchner, Michael Allgäuer, Maria Walker, Hans Kreipe, Andrea Tannapfel, Wilko Weichert, Peter Schirmacher, Daniel Kazdal, Albrecht Stenzinger

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR‐mutated lung cancer treated with the first‐/second‐generation tyrosine kinase inhibitors

    Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR‐mutated lung cancer treated with the first‐/second‐generation tyrosine kinase inhibitors... by Michael Menzel, Martina Kirchner, Klaus Kluck, Markus Ball, Susanne Beck, Michael Allgäuer, Christin Assmann, Johannes Schnorbach, Anna‐Lena Volckmar, Timothy Kwang Yong Tay, Hannah Goldschmid, Daniel SW Tan, Michael Thomas, Daniel Kazdal, Jan Budczies, Albrecht Stenzinger, Petros Christopoulos

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Endometrial stromal sarcomas with BCOR‐rearrangement harbor MDM2 amplifications

    Endometrial stromal sarcomas with BCOR‐rearrangement harbor MDM2 amplifications by Felix KF Kommoss, Kenneth TE Chang, Damian Stichel, Ana Banito, David TW Jones, Christoph E Heilig, Stefan Fröhling, Felix Sahm, Albrecht Stenzinger, Wolfgang Hartmann, Gunhild Mechtersheimer, Hans‐Peter Sinn, Dietmar Schmidt, Friedrich Kommoss, Andreas vonDeimling, Christian Koelsche

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  9. 9
    High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma

    High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma by Paul Jank, Jonas Leichsenring, Svenja Kolb, Inga Hoffmann, Philip Bischoff, Catarina Alisa Kunze, Mihnea P. Dragomir, Moritz Gleitsmann, Moritz Jesinghaus, Wolfgang D. Schmitt, Hagen Kulbe, Christine Sers, Albrecht Stenzinger, Jalid Sehouli, Ioana Elena Braicu, Christina Westhoff, David Horst, Carsten Denkert, Stefan Gröschel, Eliane T. Taube

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  10. 10
    Protocol of the IntenSify‐Trial: An open‐label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab‐paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy

    Protocol of the IntenSify‐Trial: An open‐label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab‐paclitaxel in patients with advanced stage or... by Nicolas Hohmann, Martin Ronald Sprick, Moritz Pohl, Azaz Ahmed, Jürgen Burhenne, Marietta Kirchner, Lucian Le Cornet, Markus Kratzmann, Jacek Hajda, Albrecht Stenzinger, Karen Steindorf, Stefan Delorme, Heinz‐Peter Schlemmer, Sabine Riethdorf, Ron vanSchaik, Klaus Pantel, Jens Siveke, Thomas Seufferlein, Dirk Jäger, Walter E. Haefeli, Andreas Trumpp, Christoph Springfeld

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: